NDC 81033-003-40 - Diphenhydramine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-003
- Requested NDC
- 81033-003-40
- Package NDCs from labels
- 81033-003-05, 81033-003-50, 81033-003-52, 81033-003-10, 81033-003-40, 81033-003-41
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2023-01-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diphenhydramine Hydrochloride - Kesin Pharma Corporation | Kesin Pharma Corporation | 2023-01-16 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 81033-003-41 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-189d-a2ce-e063-dadaa90aadf7 | Diphenhydramine HCl 2.5mg/mL Unit Dose Cups, 12.5mg/5 mL, 25mg/10mL |
| 81033-003-52 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-189d-a2ce-e063-dadaa90aadf7 | Diphenhydramine HCl 2.5mg/mL Unit Dose Cups, 12.5mg/5 mL, 25mg/10mL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-003-05 | Diphenhydramine Hydrochloride | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 2 | |
| 81033-003-10 | Diphenhydramine Hydrochloride | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 2 | |
| 81033-003-40 | Diphenhydramine Hydrochloride | 40 in 1 CARTON | LIQUID | 40 | 2 | |
| 81033-003-41 | Diphenhydramine Hydrochloride | 8 in 1 CASE | LIQUID | 8 | 2 | |
| 81033-003-50 | Diphenhydramine Hydrochloride | 50 in 1 CARTON | LIQUID | 50 | 2 | |
| 81033-003-52 | Diphenhydramine Hydrochloride | 8 in 1 CASE | LIQUID | 8 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-003-05 | ML - Milliliter | 81033-003 | f3701be5-9a5c-438f-b934-93806d66ebd4 | 1 | 2021-10-08 |
| 81033-003-10 | ML - Milliliter | 81033-003 | 5d902f8f-3bc7-4bea-914d-2933d9172d09 | 1 | 2021-10-08 |
| 81033-003-40 | ML - Milliliter | 81033-003 | 7ba3f437-e501-4726-9cbd-0f7dde860113 | 1 | 2021-10-08 |
| 81033-003-50 | ML - Milliliter | 81033-003 | 29f4b183-8acf-4b5d-9c82-ef7967038684 | 1 | 2021-10-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Unisom PM Pain Nighttime Sleep Aid and Pain Reliever | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Chattem, Inc. | 451daeeb-88a9-44b1-9a2d-1ff0b0ec41cb | 2026-01-14 | Warnings | TC2D6JAD40 |
| diphenhydramine hcl and zinc acetate | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | Padagis Israel Pharmaceuticals Ltd | 6d7a7615-9ae7-4c55-8a84-dba746f535d7 | 2026-01-14 | Warnings | TC2D6JAD40 |
| Unisom SleepMelts Nighttime Sleep-Aid | DIPHENHYDRAMINE HYDROCHLORIDE | Chattem, Inc. | 9105f4f1-7f94-408d-a025-83afb68dc9f0 | 2026-01-14 | Warnings | TC2D6JAD40 |
| Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | HYVEE INC | 3e608643-1a74-b474-e063-6294a90ad2e0 | 2026-01-13 | Warnings | TC2D6JAD40 |
| Rest Simply | DIPHENHYDRAMINE HYDROCHLORIDE | HYVEE INC | 462ca6cd-8eec-09df-e063-6294a90ac880 | 2026-01-13 | Warnings | TC2D6JAD40 |
| Itch Relief | DIPHENHYDRAMINE HCL, ZINC ACETATE | HY-VEE, INC | 48350b54-8d9a-48c4-e063-6394a90ac040 | 2026-01-12 | Warnings | TC2D6JAD40 |
| Allergy Relief | DIPHENHYDRAMINE HCL | H E B | c9e977b6-fba6-49ea-9d80-b43b0842bbe1 | 2026-01-12 | Warnings | TC2D6JAD40 |
| Childrens Allergy Relief | DIPHENHYDRAMINE HCL | CVS PHARMACY | 3f44cff6-240a-4a8d-aaa1-0da75a31a47b | 2026-01-12 | Warnings | 1049906 TC2D6JAD40 |
| Allergy Relief | DIPHENHYDRAMINE HCL | DOLGENCORP, LLC | bab078bb-f6b0-4394-84de-92b2c582b5da | 2026-01-12 | Warnings | TC2D6JAD40 |
| ST MORIZ SUNCARE BODY SUNSCREEN SPF30 | SUNCARE BODY SUNSCREEN SPF30 | Aopline Biotechnology (Guangzhou) Co., Ltd. | 48026f09-6d15-8fa6-e063-6294a90a17cb | 2026-01-09 | Warnings | PDC6A3C0OX |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | A-S Medication Solutions | a5809774-ed52-4f54-b48e-888631e0223d | 2026-01-09 | Warnings | TC2D6JAD40 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | A-S Medication Solutions | 5767f546-a751-4583-a8b7-971175c27ef0 | 2026-01-09 | Warnings | TC2D6JAD40 |
| Amalgam 6003 | AMALGAM | Professional Complementary Health Formulas | 1af74f69-a23a-45a2-a20e-92bf8b0ccb22 | 2026-01-08 | Warnings | TTV12P4NEE |
| Artificial Sweetener Detox 6034 | ARTIFICIAL SWEETENER DETOX | Professional Complementary Health Formulas | 38f2ae0b-2b1f-4b49-934d-fe1556f84d93 | 2026-01-08 | Warnings | 96K6UQ3ZD4 |
| Brain Enhancement Liquescence 3006 | BRAIN ENHANCEMENT LIQUESCENCE | Professional Complementary Health Formulas | 33bb2104-c16a-49e4-b292-69e10c1f16c0 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Lubricant Eye Drops Solution | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | AvPAK | f5743b38-e3d2-a065-e053-2995a90a4b9a | 2026-01-08 | Warnings | 6DC9Q167V3 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | INVAHEALTH INC | e4e4004f-77e3-569d-e053-2a95a90a73fe | 2026-01-08 | Warnings | TC2D6JAD40 |
| Preparation H Rapid Relief | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 49a93cfc-4ccd-4ef3-928f-901b9926f794 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Plus Rinse Emergency Eyewash | PURIFIED WATER | INNOVATIVE SAFETY SUPPLY INC. | b3f47d26-39e4-4aea-bb92-358def52b652 | 2026-01-08 | Warnings | 059QF0KO0R |
| pH Neutral Emergency Eyewash | WATER | INNOVATIVE SAFETY SUPPLY INC. | 29a1bd1e-d0dd-478f-e063-6394a90ab0aa | 2026-01-08 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.